Atovaquone and Proguanil Hydrochloride Tablets 250 mg (Atovaquone TABLET) 250 MG

Atovaquone and Proguanil Hydrochloride Tablets 250 mg are a combination medication used for malaria prevention and treatment. This oral tablet is manufactured by Glenmark Pharmaceuticals Canada Inc.

Strength

250 MG

Pack Size

12/100

Manufacturer / TM Owner

GLENMARK PHARMACEUTICALS CANADA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Atovaquone and Proguanil Hydrochloride Tablets are primarily used for the prevention and treatment of malaria, a mosquito-borne disease. This combination medication is often prescribed for travelers to areas where malaria is common. The tablets work by interfering with the growth of parasites in the red blood cells, helping to manage or prevent malaria infections.

Side Effects

Common effects of Atovaquone and Proguanil Hydrochloride Tablets may include nausea, vomiting, diarrhea, and headache. Some users might experience abdominal pain or loss of appetite. These effects vary among individuals and are not experienced by everyone who takes the medication.

Precautions & Warnings

Atovaquone and Proguanil Hydrochloride Tablets should be used with caution in individuals with severe kidney or liver problems. It is important to follow the prescribed dosage and complete the full course of treatment. Always consult a healthcare provider before starting this medication, especially if you have any pre-existing medical conditions or are taking other medications.

Avoid Interactions

Atovaquone and Proguanil Hydrochloride Tablets may interact with certain medications, including those that affect liver enzymes. It is advisable to avoid alcohol while taking this medication, as it can increase the risk of side effects. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions.

Frequently Asked Questions

Atovaquone and Proguanil Hydrochloride Tablets are used for the prevention and treatment of malaria, a disease caused by parasites transmitted through mosquito bites.

Atovaquone and Proguanil Hydrochloride Tablets are taken orally, typically with food or a milky drink to enhance absorption.

Common side effects may include nausea, vomiting, diarrhea, headache, abdominal pain, and loss of appetite.

Atovaquone and Proguanil Hydrochloride may interact with certain medications, so it is important to consult a healthcare provider before combining it with other drugs.

Atovaquone and Proguanil Hydrochloride should be used with caution in individuals with severe kidney or liver problems. Always consult a healthcare provider before starting this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.